AbbVie (ABBV) announced a $195 million investment in its North Chicago manufacturing facility to boost domestic API ...

Construction on the site will begin in the fall and is expected to be finished by 2027. North Chicago is already home to ...

AbbVie, a global leader in life sciences, announced Tuesday the company’s is investing $195 million to expand its North ...

The promising results, along with a separate FDA decision, could signal a major expansion of the use of the two companies' ...

AbbVie is investing $195m to strengthen domestic API production, with the expansion of its manufacturing plant in North ...

The expansion is part of AbbVie’s larger $10 billion commitment to U.S. investment in the face of Trump’s tariff threats.

AbbVie Inc.'s Q2 2025 results showcase Skyrizi & Rinvoq's growth, strong finances, and a promising pipeline. Click for my ...

AbbVie (ABBV) announced that it has completed its acquisition of Capstan Therapeutics. With the completion of the acquisition ...

AbbVie acquired Stemcentrx in a $5.8bn deal in 2016 to gain access to an ADC targeting small cell lung cancer, which ultimately failed to make a mark in clinical studies.

Over the past decade, AbbVie's shares have increased by 353.3%, or 16.3% annually, with dividends reinvested. That's ...

AbbVie's combination improved the median progression-free survival period to 9.9 months, compared with 5.8 months for a combination of Bristol-Myers Squibb's (BMY.N) Pomalyst and dexamethasone ...

The stock price of AbbVie reached its 52-week high of around $121 just last week before a recent sell-off in ABBV stock, especially after the U.S. FDA stated that all janus kinase inhibitors ...